SSY Group Announces NMPA Approvals for Oseltamivir, Drotaverine, and Metoclopramide Tablets in China 1
SSY Group Limited Announces Key Drug Approvals and Product D...
Sign in to continue:
SSY Group Limited Announces Key Drug Approvals and Product D...
Minth Group Announces Strategic Framework Agreement for Inte...
Yeebo (International Holdings) Limited - CSRC Penalty Agains...
CStone Pharmaceuticals: Nationwide Launch of Locally Manufac...
Yidu Tech Secures Major Smart Clinical Project with Sun Yat-...
Hansoh Pharmaceutical Group: Breakthrough Therapy Grant Anno...
Pa Shun International Holdings Limited Rights Issue Detailed...
Pa Shun International Holdings Limited Announces Non-Underwr...
Sunshine Oilsands Ltd. Announces Formation of Joint Venture ...
MicroPort CardioFlow Medtech Corporation: CE Approval of ENO...